Next Article in Journal
Trends in the Prevalence of Non-Alcoholic Fatty Liver Disease and Its Future Predictions in Korean Men, 1998–2035
Previous Article in Journal
The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936

by
Alessandra V. S. Faria
1,2,
Sheila S. Andrade
3,
Agnes N. Reijm
1,
Manon C. W. Spaander
1,
Moniek P. M. de Maat
4,
Maikel P. Peppelenbosch
1,
Carmen V. Ferreira-Halder
2,* and
Gwenny M. Fuhler
1,*
1
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, NL-3000 CA Rotterdam, The Netherlands
2
Department of Biochemistry and Tissue Biology, University of Campinas, UNICAMP, Campinas, SP 13083-862, Brazil
3
PlateInnove Biotechnology, Piracicaba, SP 13414-018, Brazil
4
Department of Hematology, Erasmus University Medical Center Rotterdam, NL-3000 CA Rotterdam, The Netherlands
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(8), 2625; https://doi.org/10.3390/jcm9082625
Submission received: 30 July 2020 / Accepted: 7 August 2020 / Published: 13 August 2020
(This article belongs to the Section Hematology)
The authors wish to make the following correction to their paper [1], published on 28 June 2019 in Journal of Clinical Medicine. Figure 1A in the published version is incorrect due to the authors’ carelessness. The authors sincerely apologize for this mistake to all the readers. The journal office has checked the review history and found all drafts of the article used the correct picture for Figure 1A apart from the final publication version. Thus, this correction does not alter the interpretation or conclusions drawn from the present study.
Figure 1 should be replaced with the following, correct picture:
Jcm 09 02625 i001
The published version will be updated online on the article webpage, with a reference to this correction.

Reference

  1. Faria, A.V.S.; Andrade, S.S.; Reijm, A.N.; Spaander, M.C.W.; de Maat, M.P.M.; Peppelenbosch, M.P.; Ferreira-Halder, C.V.; Fuhler, G.M. Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936. [Google Scholar] [CrossRef] [PubMed] [Green Version]

Share and Cite

MDPI and ACS Style

Faria, A.V.S.; Andrade, S.S.; Reijm, A.N.; Spaander, M.C.W.; de Maat, M.P.M.; Peppelenbosch, M.P.; Ferreira-Halder, C.V.; Fuhler, G.M. Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936. J. Clin. Med. 2020, 9, 2625. https://doi.org/10.3390/jcm9082625

AMA Style

Faria AVS, Andrade SS, Reijm AN, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM. Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936. Journal of Clinical Medicine. 2020; 9(8):2625. https://doi.org/10.3390/jcm9082625

Chicago/Turabian Style

Faria, Alessandra V. S., Sheila S. Andrade, Agnes N. Reijm, Manon C. W. Spaander, Moniek P. M. de Maat, Maikel P. Peppelenbosch, Carmen V. Ferreira-Halder, and Gwenny M. Fuhler. 2020. "Correction: Faria, A.V.S. et al., Targeting Tyrosine Phosphatases by 3-Bromopyruvate Overcomes Hyperactivation of Platelets from Gastrointestinal Cancer Patients. J. Clin. Med. 2019, 8, 936" Journal of Clinical Medicine 9, no. 8: 2625. https://doi.org/10.3390/jcm9082625

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop